Integrating Artificial Tear Formulations and Neuromodulation in the Management of Ocular Surface Disease

Complimentary

Enduring Webcast
Released on 6/22/26
Expires on 6/22/27

Take Me to the Event Activity

Program Description

This enduring webcast will provide up-to-date, evidence-based information on pathophysiology, evaluation, artificial tear formulations, and neuromodulation in managing OSD.

Intended Audience

This activity is designed to meet the educational needs of ophthalmologists, optometrists, advanced practice providers (physician assistants and nurse practitioners), and nurses who manage patients with ocular surface disease (OSD).

Commercial Supporter

Supported by an unrestricted educational grant from Alcon Vision, LLC.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Integrate the evidence-based information on pathophysiology, risk factors, and evaluation of ocular surface disease.
  • Implement data on artificial tear formulations and neuromodulation in managing ocular surface disease.

Accredited Providers


This activity is jointly provided by Amedco and MedNet.

   

Joint Accreditation Statement


In support of improving patient care, this activity has been planned and implemented by Amedco and MedNet. Amedco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians Credit Designation


Amedco designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Credit Information


Note to Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allows reciprocity for AANPCP continuing education credit. 1.25 hours.

Note to Physician Assistants
PAs may claim a maximum of 1.25 AMA PRA Category 1 CreditsTM for completing this activity. NCCPA accepts AMA PRA Category 1 CreditsTM from organizations accredited by ACCME or a recognized state medical society.

Through an agreement between the American Medical Association (AMA) and the European Union of Medical Specialists, physicians and healthcare providers may convert AMA PRA Category 1 CreditsTM to an equivalent number of European CME Credits® (ECMECs®). The UEMS-EACCME® has recognition agreements with the AMA for live events and e-learning materials.

Conflicts of Interest Disclosure Policy


Amedco and MedNet adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME/CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Accredited Provider Disclosures


Amedco staff have no relevant financial relationships to disclose.

Planners’ and Managers’ Disclosures


MedNet staff have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use


This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a clinician relative to diagnostic and treatment options for a specific patient’s medical condition.

Disclaimer


The opinions expressed in this enduring material are those of the faculty and do not necessarily represent the views of Amedco, MedNet, and Alcon Vision, LLC.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

If you have any questions relating to the accreditation of this activity, please contact certificate@amedcoemail.com.

Faculty

Ian Pitha, MD, PhD
Glaucoma Specialist
Associate Director of the Alan S. Crandall Center for Glaucoma Innovation at Moran Eye Center
University of Utah Salt
Lake City, Utah

Dr. Pitha discloses the following:
Consultant: W.L. Gore and Associates, iCare, and Halia
Grant: W.L. Gore and Associates, Vialase, and Hexiris
Medical Advisory Board: EyeX

 

Stephen Pflugfelder, MD
Professor and James and Margaret Elkins Chair in Ophthalmology
Baylor College of Medicine
Houston, TX

Dr. Pflugfelder discloses the following:
Consultant: Alcon, Dompé
Equity Interest: Unfold, Inc

The following relationships have ended within the last 24 months:
Consultant: Kala, Kowa

All relevant financial relationships for these individuals have been mitigated.

Instructions

In order to receive CME/CE credits, participants must complete the pre-assessment questions, post-assessment, and program evaluation. Participants must also score at least 75% on the post-assessment. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Dashboard or Transcript, which you can access at any time.